Evidence map›Paper›PMID 37119806›Full record

ArticleG3 (Bethesda, Md.)2023

A comprehensive in vivo screen of yeast farnesyltransferase activity reveals broad reactivity across a majority of CXXX sequences.

June H Kim, Emily R Hildebrandt, Anushka Sarkar, Wayland Yeung, La Ryel A Waldon, Natarajan Kannan, Walter K Schmidt

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Renaissance of farnesyltransferase inhibitors in cancer.Journal of translational medicine · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Physiological adventures inMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  10. Comprehensive analysis of CXXX sequence space reveals thatbioRxiv : the preprint server for biology · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

June H KimDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Emily R HildebrandtDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Anushka SarkarDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Wayland YeungInstitute of Bioinformatics, University of Georgia, Athens, GA 30602, USA.
La Ryel A WaldonDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Natarajan KannanDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Walter K SchmidtDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
University of Georgia · US

Funding

Determining the scope of prenylatable protein sequencesR01GM132606 · NIGMS · UNIVERSITY OF GEORGIA · PI KANNAN, NATARAJAN, SCHMIDT, WALTER K · 2019 to 2022
$1.6M
NIGMS NIH HHS R01 GM132606
6 · The paper itself

Abstract

The current understanding of farnesyltransferase (FTase) specificity was pioneered through investigations of reporters like Ras and Ras-related proteins that possess a C-terminal CaaX motif that consists of 4 amino acid residues: cysteine-aliphatic1-aliphatic2-variable (X). These studies led to the finding that proteins with the CaaX motif are subject to a 3-step post-translational modification pathway involving farnesylation, proteolysis, and carboxylmethylation. Emerging evidence indicates, however, that FTase can farnesylate sequences outside the CaaX motif and that these sequences do not undergo the canonical 3-step pathway. In this work, we report a comprehensive evaluation of all possible CXXX sequences as FTase targets using the reporter Ydj1, an Hsp40 chaperone that only requires farnesylation for its activity. Our genetic and high-throughput sequencing approach reveals an unprecedented profile of sequences that yeast FTase can recognize in vivo, which effectively expands the potential target space of FTase within the yeast proteome. We also document that yeast FTase specificity is majorly influenced by restrictive amino acids at a2 and X positions as opposed to the resemblance of CaaX motif as previously regarded. This first complete evaluation of CXXX space expands the complexity of protein isoprenylation and marks a key step forward in understanding the potential scope of targets for this isoprenylation pathway.

Indexed as

Alkyl and Aryl TransferasesSaccharomyces cerevisiaeAmino Acid SequenceFarnesyltranstransferaseProtein PrenylationProteinsSubstrate SpecificityAlkyl and Aryl TransferasesFarnesyltranstransferaseProteinsfarnesyltransferasenext-generation sequencingprotein farnesylationsubstrate specificityyeast genetics

Identifiers

PMID37119806
PMCPMC10320760
OpenAlexW4367553249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.